BioLine RX Ltd Long-term Investment Intensity
BioLine RX Ltd long-term investment intensity. BioLine RX Ltd (BLRX) has a Long-term Investment Intensity of 1.8% as of March 2018. Long-term investments of ILA1.00 Million represent 1.8% of total assets of ILA56.08 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See BLRX current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of BioLine RX Ltd (2017–2017)
Long-term investment intensity of BioLine RX Ltd from 2017 to 2017. This chart shows how BioLine RX Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2017 to 2017. As of March 2018, the intensity stands at 1.8%, reflecting long-term investments of ILA1.00 Million against total assets of ILA56.08 Million ILA. See BLRX cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
BioLine RX Ltd Long-term Investment Intensity by Year (2017–2017)
BioLine RX Ltd long-term investment intensity by year from 2017 to 2017. The table below presents the year-by-year Long-term Investment Intensity for BioLine RX Ltd from 2017 to 2017, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see BioLine RX Ltd balance sheet assets.
| Year | LT Investment Intensity | LT Investments (ILA) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2017 | 1.6% | ILA1.00 Million | ILA60.97 Million | — |